CA2126554A1 - Traitement des mouvements involontaires par des agonistes des recepteurs 5ht1a - Google Patents

Traitement des mouvements involontaires par des agonistes des recepteurs 5ht1a

Info

Publication number
CA2126554A1
CA2126554A1 CA002126554A CA2126554A CA2126554A1 CA 2126554 A1 CA2126554 A1 CA 2126554A1 CA 002126554 A CA002126554 A CA 002126554A CA 2126554 A CA2126554 A CA 2126554A CA 2126554 A1 CA2126554 A1 CA 2126554A1
Authority
CA
Canada
Prior art keywords
phenyl
represented
indol
ethyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002126554A
Other languages
English (en)
Inventor
Martin Galvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2126554A1 publication Critical patent/CA2126554A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002126554A 1992-01-07 1992-12-07 Traitement des mouvements involontaires par des agonistes des recepteurs 5ht1a Abandoned CA2126554A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400032 1992-01-07
EP92400032.6 1992-01-07

Publications (1)

Publication Number Publication Date
CA2126554A1 true CA2126554A1 (fr) 1993-07-22

Family

ID=8211593

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002126554A Abandoned CA2126554A1 (fr) 1992-01-07 1992-12-07 Traitement des mouvements involontaires par des agonistes des recepteurs 5ht1a

Country Status (5)

Country Link
AU (1) AU3241093A (fr)
CA (1) CA2126554A1 (fr)
MX (1) MX9300035A (fr)
WO (1) WO1993013766A1 (fr)
ZA (1) ZA9312B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy
GB0027020D0 (en) 2000-11-03 2000-12-20 Univ Manchester Treatment of movement disorders
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease
EP3160464B1 (fr) * 2014-06-26 2018-07-18 Contera Pharma APS 6-hydroxybuspirone destiné au traitement de troubles du mouvement
CN111116451A (zh) * 2020-01-16 2020-05-08 宁波大学 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642497A1 (de) * 1986-12-12 1988-06-23 Hoechst Ag Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte

Also Published As

Publication number Publication date
AU3241093A (en) 1993-08-03
WO1993013766A1 (fr) 1993-07-22
ZA9312B (en) 1993-08-05
MX9300035A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
US5559143A (en) Serotonin 5HT1A agonistic method
MXPA03011448A (es) Derivados de n-arilfenilacetamida y composicion farmaceutica que los contienen.
JP4939396B2 (ja) Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
CA2100944A1 (fr) 3-(hydroxybenzylidenyl)-indoline-2-ones, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA3077732A1 (fr) Promedicaments de type ester de [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol pour le traitement de maladies retiniennes
JPH02295924A (ja) 刺激性アミノ酸拮抗剤
KR20240009433A (ko) 실로시빈의 제형
JP2004532185A5 (fr)
JP2001520674A (ja) ペプチジル−２−アミノ−１−ヒドロキシアルカンスルホン酸システインプロテアーゼインヒビター
CA2126554A1 (fr) Traitement des mouvements involontaires par des agonistes des recepteurs 5ht1a
AU2009330131A1 (en) Compounds and methods for the treatment of pain and other diseases
KR100749991B1 (ko) 인돌 유도체
JP2846895B2 (ja) 抗痙攣用または神経保護用医薬
FR2680172A1 (fr) Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
JP5236748B2 (ja) 疼痛治療のためのカンナビノイド受容体のリガンドとしてのプロリン類似体
JP2002541077A (ja) Ｎｏ合成酵素阻害剤と代謝酸化防止剤の組み合わせ
US11225459B2 (en) Substituted bisphenylalkylurea compounds and methods
EP1146044B1 (fr) Dérivés de cyclobuta-indole carboxamide agissant sur le système nerveux central, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JPH08503448A (ja) ５ｈｔ▲下１▼▲ａ▼受容体アゴニストによる不随意運動の処置
CN108069833B (zh) 苯并四环衍生物及其制备方法和在医药上的应用
JP4976499B2 (ja) キマーゼ阻害剤としてのビニル酸誘導体
LU83021A1 (fr) Nouveaux derives de l'amino-1 propanol-2,leur procede de preparation et leur application therapeutique
HU199790B (en) Process for producing beta-/fluoromethylene/-5-hydroxy-tryptophan derivatives and pharmaceutical compositions comprising same
KR20090100443A (ko) 심혈관 질환 치료용 1,3-디히드로이미다졸
JP2003504396A (ja) マクロライド化合物の新規用途

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 19960609